TAS
STLN

TIFF Advisory Services’s Starling Oncology STLN Stock Holding History

TIFF Advisory Services’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-195,469
Closed -$565K – 24
2026
Q1 		$565K Sell
195,469
-100
-0.1% -$307 0.13% 25
2025
Q4 		$696K Sell
195,569
-661,059
-77% -$2.45M 0.12% 19
2025
Q3 		$2.99M Sell
856,628
-2,777,837
-76% -$9.52M 0.62% 18
2025
Q2 		$7.45M Buy
3,634,465
+655,324
+22% +$1.64M 1.76% 10
2025
Q1 		$3.4M Hold
2,979,141
– – 0.81% 10
2024
Q4 		$921K Buy
2,979,141
+346,256
+13% +$89.8K 0.3% 18
2024
Q3 		$861K Buy
2,632,885
+1,214,200
+86% +$503K 0.29% 19
2024
Q2 		$653K Buy
1,418,685
+995,280
+235% +$849K 0.23% 20
2024
Q1 		$669K Hold
423,405
– – 0.29% 16
2023
Q4 		$864K Hold
423,405
– – 0.41% 18
2023
Q3 		$593K Buy
+423,405
New +$438K 0.49% 15

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TIFF Advisory Services's STLN Position: Q2 2026 in Review

TIFF Advisory Services sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 195,469 shares — an estimated $565K sold.

TIFF Advisory Services first reported a position in STLN in Q3 2023 and held it in 11 quarters. The position peaked at $7.45M in Q2 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • TIFF Advisory Services reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • TIFF Advisory Services sold 195,469 Starling Oncology shares in Q2 2026, an estimated $565K.
  • TIFF Advisory Services first reported a position in Starling Oncology in Q3 2023 and held it in 11 quarters.
  • TIFF Advisory Services's Starling Oncology position peaked at $7.45M in Q2 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on TIFF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.